ArriVent BioPharma
$23.68
1
+$0.61+2.64% Today
Statistics
Day High
24.19
Day Low
23.18
52W High
27.22
52W Low
15.47
Volume
107,971
Avg. Volume
499,757
Mkt Cap
977.53M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
13MayExpected
Expected EPS
-0.894671
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-160.98MNet Income
Analyst Ratings
$42.80Average Price Target
The highest estimate is 50.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow AVBP. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
Show more...
CEO
Dr. Zhengbin Yao Ph.D.
Employees
52
Country
US
ISIN
US04272N1028
Listings
0 Comments
Share your thoughts
FAQ
What is ArriVent BioPharma stock price today?▼
The current price of AVBP is $23.68 USD — it has increased by +2.64% in the past 24 hours. Watch ArriVent BioPharma stock price performance more closely on the chart.
What is ArriVent BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ArriVent BioPharma stocks are traded under the ticker AVBP.
Is ArriVent BioPharma stock price growing?▼
AVBP stock has risen by +4.22% compared to the previous week, the month change is a +3.22% rise, over the last year ArriVent BioPharma has showed a +31.5% increase.
What is ArriVent BioPharma market cap?▼
Today ArriVent BioPharma has the market capitalization of 977.53M
When is the next ArriVent BioPharma earnings date?▼
ArriVent BioPharma is going to release the next earnings report on May 13, 2026.
What were ArriVent BioPharma earnings last quarter?▼
AVBP earnings for the last quarter are -0.84 USD per share, whereas the estimation was -0.85 USD resulting in a +0.78% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ArriVent BioPharma revenue for the last year?▼
ArriVent BioPharma revenue for the last year amounts to 0 USD.
What is ArriVent BioPharma net income for the last year?▼
AVBP net income for the last year is -160.98M USD.
How many employees does ArriVent BioPharma have?▼
As of April 01, 2026, the company has 52 employees.
In which sector is ArriVent BioPharma located?▼
ArriVent BioPharma operates in the Health Care sector.
When did ArriVent BioPharma complete a stock split?▼
ArriVent BioPharma has not had any recent stock splits.
Where is ArriVent BioPharma headquartered?▼
ArriVent BioPharma is headquartered in Newtown Square, US.